New targeted therapies allow for the treatment of a disease that is already the fifth leading cause of fatal tumors globally ...

Metastatic prostate cancer can progress in different ways. In some men the disease advances rapidly, while other men have ...

A medical revolution quietly unfolds on Hainan, allowing patients to access cutting-edge therapies before they hit the market ...

A common class of antidepressant medications might be even more useful than we thought. Research out today suggests that ...

From trial phases to personalized care, here’s how healthcare providers can navigate cancer clinical trials and guide ...

The FDA has placed a clinical hold on the study while Rocket works with trial monitors and experts to investigate the cause ...

In an interview, Aditya Shreenivas, MD, MS, discussed the approval of penpulimab in nasopharyngeal carcinoma and the study ...

Already a Vigil Neuroscience investor, Sanofi has agreed to buy the rest of the biotech’s shares for $8 apiece, representing ...

No, not those sorts of drugs, the kinds that could save your life.